Literature DB >> 9153343

Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.

H J Anders1, J R Bogner, F D Goebel.   

Abstract

Adverse drug reactions to trimethoprim-sulfamethoxazole (TMP/SMX) are common in HIV-positive patients. However, only one case of TMP/SMX-related rhabdomyolysis has been reported, so far. We report a 55-year old-man with asymptomatic rhabdomyolysis after oral high-dose TMP/SMX for suspected PCP. Laboratory changes settled after discontinuation of the drug.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9153343

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN： 0949-2321            Impact factor:   2.175


  4 in total

1.  Mild rhabdomyolysis in a child with fever and "hematuria".

Authors:  Velibor Tasic; Vladimir Avramoski; Petar Korneti
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

2.  Rhabdomyolysis in a Patient with Severe Hypothyroidism.

Authors:  Nooshin Salehi; Endre Agoston; Iqbal Munir; Gary J Thompson
Journal:  Am J Case Rep       Date:  2017-08-22

3.  Trimethoprim-sulfamethoxazole-induced hyperkalemia in a patient with normal renal function.

Authors:  L Connor Nickels; Christine Jones; Latha Ganti Stead
Journal:  Case Rep Emerg Med       Date:  2012-12-13

4.  Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant.

Authors:  Alexander Augustyn; Mona Lisa Alattar; Harris Naina
Journal:  Case Rep Oncol Med       Date:  2015-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.